V5 Ultimate
Manufacturing · The complete guide

Cleaning Validation MAC

TL;DR

Cleaning validation proves that a documented cleaning procedure consistently reduces residue from one product to a level that is safe in the next product manufactured on the same equipment. The maximum allowable carryover (MAC) limit is the keystone calculation — historically the lower of 10 ppm in the next product, 1/1000 of the lowest therapeutic dose, or visually clean — but since EMA's 2014 guideline + PIC/S PI 046-1 (2018) the dominant approach is the health-based exposure limit (HBEL), derived from a toxicological PDE / ADE. Three consecutive successful cleaning runs, with documented swab + rinse recovery and visual inspection, constitute the validation. Cleaning failures are the #1 driver of cross-contamination 483s in multi-product facilities.

Reviewed · By V5 Ultimate compliance team· 2,700 words · ~13 min read

01Maximum Allowable Carryover — the three historical bases

BasisFormulaComment
10 ppm in next productMAC = 10 ppm × BatchSize_next ÷ SharedSurfaceDefault ceiling for many older programmes; not toxicologically justified for high-potency
1/1000 of lowest therapeutic doseMAC = (LTD_prev ÷ 1000) × BatchSize_next ÷ MaxDailyDose_nextPre-EMA-2014 'Fourman & Mullen' approach; useful for typical-potency drugs but inadequate for highly active / cytotoxic
Visually cleanVisual inspection criterion of equipment surfaces; typically 4 μg/cm² detectabilityRequired complementary criterion; never the only criterion
Health-Based Exposure Limit (HBEL / PDE)MAC = (PDE × BatchSize_next) ÷ (MaxDailyDose_next × SharedSurface)Post-EMA 2014 / PIC/S 2018 dominant approach; toxicologically derived per ICH Q3C / Q3D-style PDE

02Sampling methods + recovery

  • Swab sampling — defined-area swab (typical 25 – 100 cm²) using validated swab type (polyester, cotton, sponge); extraction into a defined solvent; HPLC / TOC / specific assay. Direct measurement at the worst-case surface. Recovery must be established per-substance per-surface per-swab.
  • Rinse sampling — final rinse of the equipment collected and analysed; integrates over the entire wetted surface. Lower sensitivity than swab per area but covers inaccessible surfaces.
  • Visual inspection — operator + supervisor visual confirmation; documented checklist; supplemented by white-light + UV-light inspection where appropriate; complementary to swab + rinse, never the only method.
  • Recovery study — for each surface material (316L SS, glass, silicone) × each analyte: spike known mass per area, allow drying, swab, extract, analyse; calculate % recovery; correct MAC measurement by recovery factor. Recoveries < 50% are flagged for method improvement; < 30% usually unacceptable.

03Worst-case bracketing — product / equipment grouping

Most facilities manufacture multiple products on shared equipment. Validating cleaning for every product × every equipment combination is impractical. Instead: group products by similarity (potency, solubility, cleaning difficulty); identify the worst-case product in each group (lowest PDE, lowest solubility, most difficult to clean, highest active concentration); validate cleaning for the worst-case; bracket the rest. Equipment grouping similar — identify worst-case equipment (most complex geometry, hardest-to-clean surfaces); validate that one; bracket geometrically similar equipment.

04Dirty + clean hold times

  • Dirty hold time (DHT) — maximum time between end of manufacture and start of cleaning. Beyond DHT, residue dries, hardens, or transforms (e.g. proteins denature) and the validated cleaning may no longer be effective. DHT is established by qualification studies — hold equipment with residue for the proposed time, then clean, then verify MAC.
  • Clean hold time (CHT) — maximum time between end of cleaning and start of next manufacture. Beyond CHT, microbial regrowth may occur. CHT established by post-cleaning bioburden + endotoxin testing at the proposed time.
  • Both DHT + CHT are documented in the cleaning procedure; deviation requires re-cleaning + (for CHT) re-disinfection; routine adherence tracked.

05The three-run validation contract

Cleaning validation requires three consecutive successful cleaning runs — each following the documented procedure, sampled per the protocol, evaluated against MAC + bioburden + visual criteria. Three is the industry default rooted in FDA's 1993 guide. The runs should span typical operational conditions (different operators, different shifts where applicable, equipment in typical condition). Three successes do not 'prove' the cleaning works forever — they confirm validation status at that point; ongoing verification (CPV-style) keeps the validation alive.

06Ongoing verification + change triggers

  • Per-cleaning verification — at each commercial-batch cleaning event, visual inspection + (typically) periodic swab or rinse sample at a routine cadence; trend.
  • Change triggers re-validation — new product (re-evaluate against the existing worst-case + bracketing), formulation change (re-assess solubility + PDE), equipment change, cleaning agent change, surface material change.
  • Trend signals — periodic-verification swab drift, visual fails, manufacturing investigations attributing root cause to cross-contamination, microbial recovery trend.
  • Periodic re-qualification — typical 3 – 5 year cycle even without change, especially for high-potency / cytotoxic.

07Common failure modes

  • Carryover calculation using 10 ppm or 1/1000 only, no HBEL — inadequate for high-potency products; EMA / MHRA inspection cite.
  • PDE established without qualified toxicologist sign-off — challenged at inspection.
  • Recovery study done at one concentration only — non-linear recovery across the MAC range goes undetected.
  • Visual-clean as the only criterion — limit of detection ~ 4 μg/cm²; many high-potency MAC limits are below visual detectability.
  • Dirty hold time not qualified — operations hold dirty equipment > qualified time; cleaning then fails MAC.
  • Worst-case product chosen on potency alone, ignoring solubility — least-soluble product may be harder to clean than the most-potent.
  • Cleaning agent changed (e.g. from CIP-100 to alternative) without re-validation.
  • Same cleaning procedure used across CIP + manual — actually a different cleaning, never validated separately for the manual operator-variability case.
  • Disinfectant + cleaning agent treated as one programme — disinfectant log shows rotation but cleaning-agent effectiveness against soil never re-challenged.
  • Periodic-verification trend showing drift toward alert ignored — fails at next regulatory inspection.

08How V5 Ultimate runs cleaning validation

  • Per-product PDE register: PDE μg/day + toxicologist + literature basis + review date; change-controlled.
  • MAC calculator: per equipment × product-previous × product-next combination; HBEL, 10 ppm, 1/1000 calculations side-by-side; applied limit = most restrictive.
  • Worst-case bracketing register: product groups + worst-case justification + bracket coverage statement; auto-update when a new product joins a group.
  • Validation protocol + record: three-run protocol; per-run sample-point map + result entry + visual inspection sign-off; pass / fail per run; consecutive-success counter.
  • Recovery study register: per analyte × surface × swab × diluent; recovery % + range; auto-applied to MAC measurements.
  • DHT / CHT qualification + adherence: every cleaning event tagged with prior-batch end + cleaning start + next-batch start; out-of-window events trigger deviation.
  • Per-cleaning verification: routine swab / visual schedule per equipment; per-event record; trend with alert / action.
  • Change-control linkage: product change / equipment change / agent change auto-routes to cleaning-validation impact assessment.
  • Equipment-status gate: equipment cannot be released to next product if cleaning validation is expired, in-investigation, or fails verification.
  • Inspection pack: per-equipment cleaning history + validation protocols / reports + verification trend + DHT/CHT adherence — exports as one PDF.

Frequently asked questions

Q.Is the 10 ppm rule still acceptable?+

Only as a complementary not a sole limit. Post-EMA 2014, HBEL is the toxicologically defensible primary basis; 10 ppm + 1/1000 are sanity-check caps. For high-potency / cytotoxic / sensitiser products, 10 ppm is far too loose and inspectors will reject it.

Q.Who can set the PDE?+

A qualified toxicologist (typically board-certified DABT, ERT, or equivalent) with documented justification per EMA / PIC/S methodology. Many sites contract this out; the documented PDE rationale is the regulated artifact.

Q.Three runs — is that mandated?+

Not mandated by rule but is the industry-default convention rooted in the 1993 FDA cleaning-validation guide and consistent with process-validation 3-batch convention. Some sites justify 5 runs for high-stakes products; three is the floor.

Q.Do we have to swab every surface?+

No — risk-based worst-case surface selection (hardest to clean, most product contact). The worst-case justification is captured in the protocol.

Q.What about dedicated equipment?+

Dedicated equipment (one product, never shared) does not require cross-contamination MAC — only product-residue carryover between batches of the same product (typically negligible) + bioburden control. Documentation still required.

Q.How does cleaning validation interact with sterile-facility disinfection?+

Cleaning validation removes chemical residue. Disinfection (Annex 1 + USP <1072>) reduces microbial bioburden. Sterile facilities need both; the cleaning-then-disinfection sequence is a single validated procedure with chemical-residue + microbial endpoints.

Primary sources

Further reading

See Cleaning Validation MAC working on a real shop floor

V5 Ultimate ships with the Cleaning Validation MAC controls already wired in — audit trail, e-signatures, validation evidence. Free trial, no credit card, onboard in days, not months.